Not yet recruitingNot applicableNCT07222592

MOBoxy: MoblO2 to Maintain Oxygenation

Studying Interstitial lung disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Jewish Health
Principal Investigator
Jeff Swigris, DO, MS
National Jewish Health
Intervention
MoblO2 control(device)
Enrollment
48 enrolled
Eligibility
25 years · All sexes
Timeline
20252026

Study locations (1)

Collaborators

National Heart, Lung, and Blood Institute (NHLBI) · Stanford University · Minnesota Health Solutions

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07222592 on ClinicalTrials.gov

Other trials for Interstitial lung disease

Additional recruiting or active studies for the same condition.

See all trials for Interstitial lung disease

← Back to all trials